ndida albicans, a member of the normal human gasintestinal flora, is a major cause of opportunistic fungal infection in immunocompromised hosts, especially those with hematologic malignancies (1, 2) and AIDS (3) . The complex array of factors, both host related (4) , and pathogen related (5) , that are responsible for the virulence of C. albicans under these circumstances have been the subject of considerable study. Factors that have been implicated in the virulence of C. albicans include the ability of the organism to form germ tubes (6, 7) , to produce toxins and hydrolytic enzymes (8, 9) , and to adhere to and invade host tissues (10, 11) .
C. albicans expresses cell surface proteins that bind C3 degradation fragments, and as such appear to be functional homolognes of mammalian complement receptors (CR) (12) (13) (14) (15) . Expression of CR-like molecules by C. albicans was discovered when it was observed that C. albicans hyphae could rosette complement-coated sheep erythrocytes (12) . The function of the Candida CR-like molecules is unknown, but CIL expression appears to be associated with the more pathogenic species of Candida (12, 13, 16) , thus implicating the receptors in virulence of the organism.
C. albicans is growth inhibited in human serum (17) (18) (19) . Although several possibilities have been suggested to account for this inhibition (20) (21) (22) , a number of reports have correlated inhibition with the presence of transferrin (18, 23, 24) . Transferrin is a serum protein that binds iron with high affinity, restricting free iron to levels insuf~cient for microbial growth (25) . Since iron is essential for a variety of cellular metabolic processes, pathogenic microorganisms must have mechanisms for obtaining iron that is sequestered by the host (25) . The mechanism(s) by which C. albicans acquires iron for growth in the iron-restricted environment of the human host have not been extensively investigated.
Since hemoglobin is a rich iron source, the ability of C. albicans to rosette complement-coated RBC led us to investigate the possibility that C. albicans obtains iron from receptor-bound RBC. In the present study we demonstrate that C. albicans utilizes hemoglobin from RBC as an iron source. In addition, we show that C. albicans uses CR-like molecules to bind complement-coated RBC, allowing the fungus to obtain RBC-derived iron for growth. A mechanism by which this mode of iron acquisition may occur in vivo is suggested by the fact that activation of the alternative complement pathway by Candida cultured in fresh human serum leads to deposition on surrounding, autologous RBC of the C3-derived ligands necessary for Candida-RBC rosetting.
Materials and Methods
Iron Compounds. Fe 
Assays fir Serum-induced Growth Inhibition Of C albicans. Yeast
phase organisms from 24-h SDA plate cultures were washed with sterile saline and resuspended in RPMI 1640 supplemented with ghitamine, penicillin, and streptomycin (R.PMI medium) plus the indicated concentrations of heat-inactivated (56~ 45 rain) pooled normal human serum (NHS). Yeasts were plated at 250/well in polystyrene microtiter dishes and incubated at 37~ with 5%
COz. C albicans cultured under the above conditions convert from the yeast to the hyphal form in the presence or absence of human serum (26, 27) . The extent of hyphal growth after 18 h of culture was determined by [3H]glucose uptake assay (26, 27) and by MTT assay (28) .
[~H]Glucose Uptake Assay. Assay for Candida hyphal growth by uptake of radiohbded glucose has been described in detail elsewhere (26, 27) . Briefly, after 18 h of growth under the described experimental conditions, medium was removed, wells were washed with sterile distilled water, and 25 #1 of 2,5[3H]glucose (Net-807, sp act 67 Ci/mMol; New England Nuclear, Boston, MA), diluted to 10 #Ci/ml in sterile water, was added to each well. Plates were incubated for 30 min at 37~ 25 #1 bleach was added to wells to remove phstic-adherent hyphae, and radiohbeled C. albicans were harvested onto glass fiber filters using an automatic cell harvester.
Radioactivity incorporated into C albicans hyphae, which is proportional to the amount of hyphal growth (26, 27) , was counted in a liquid scintillation counter.
MTTAssay. Quantitation of Candida growth by tetrazoliumbased colorimetric assay was performed as described by Lavitz and Diamond (28 
Pre~ration of Radiolakeled Rat RBC (RRBC). SgFe-hbeled
RRBC were obtained from anemic Sprague-Dawley rats according to the method described by Pippard et al. (31) . SgFe-labeled RRBC were opsonized using the method described for SRBC, except red cells were coated with anti-RRBC IgM, 1:1,500 dilution, (Accurate Chemical Co., Westbury, NY) before the deposition of complement.
Assar for Uptake of Iron from Radiolabeled RRBC by C. albicans H2/phae. 2 x 104 yeasts were cultured in polypropylene microfuge tubes at 37~ in RPMI medium plus 0.25% heatinactivated NHS. After 18 h, hyphae were washed and incubated for an additional 2 h with 107 complement-opsonized or unopsonized SgFe-RRBC diluted in RPMI medium plus 2.5% heatinactivated CSds. Hyphae were washed with HBSS + 0.1% BSA, followed by three washes with water to lyse RRBC, and a final wash with HBSS-BSA to remove unincorporated radiolabd. The amount of SgFe taken up after 2 h by C. albicans hyphae was counted in a gamma counter.
"~Bystander" Rosetting of Human RBC (HRBC) to C. albicans.
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Candida Complement Receptors and Iron Acquisition 5 x 103 yeasts were cultured in individual wells of 96-well mierotiter dishes at 37~ in RPMI medium plus 0.25% NHS. After 18 h, medium was removed and 5 x 106 HRBC diluted in 50/~1 RPMI medium plus 10% autologous fresh serum, heat-inactivated serum, C3-depleted serum, or fresh serum treated with EDTA or EGTA/Mg 2+ were added to the wells. After 1 h at 37~ wells were washed gently three times to remove excess unbound HRBC and cultures were scored blindly for the presence of C. albicans-HRBC rosettes. For a quantitative assay of rosetting, the amount of hemoglobin associated with C. atbi~ns-HRBC rosettes was measured. 5 x 103 (7, . albicans yeasts were grown in RPMI medium with 0.25% NHS for 18 h in 1.5-ml microcentrifuge tubes. Medium was removed and hyphae were resuspended in a 50-/~1 volume of serum plus 2.5 x 107 HRBC. After 1 h at 37~ 200/~1 medium was added and the tubes were incubated for an additional I h, during which time nourosetted HRBC settled into a pellet below the hyphae. Hyphae were carefully removed to fresh tubes without disturbing the unbound RBC pellet, washed once, and resuspended in water to lyse bound RBC. The amount of hemoglobin released by bound RBC was measured by determining the absorbance at 420 nm.
Flow C),tometry. HRBC for flow cytometry analysis were obtained from rosetted and nourosetted cultures containing C albicans hyphae and fresh or heat-inactivated autologous serum, respectively. Wells were washed three times gently to remove excess unbound HRBC from the wells, fo[iowed by more vigorous washing to remove remaining rosetted and nonrosetted HRBC. Cells obtained in this manner were assayed for the presence of complement by incubating for 45 min on ice with a 1:15 dilution of monoclonal anti-iC3b followed by goat anti-mouse Ig-FITC (National Cancer Institute Repository, Bethesda, MD). C. albicans hyphae, which are firmly adherent to plastic, are not removed from the wells by this procedure. Fluorescence analysis was performed on a FACScan | analyzer (Becton Dickinson & Co.).
Results
Inhibition of C. albicans Growth in Human Serum and Restoration of Growth by Ferric Nitrate and Hemoglobin.
Growth of C. albicans hyphae was dramatically inhibited in the presence of increasing concentrations of heat-inactivated NHS, as indicated by a dose-dependent decrease in the uptake of radiolabded glucose into hyphae (Fig. 1 A) . Serum-induced growth inhibition was also reflected by a dose-dependent decrease in the reduction of M T T to MTT-formazan by C. al-b/cans, as well as by colony size (Fig. 1, A and B) . This inhibitory effect was reproduced by substituting 10 #g/ml purified human apotransferrin for serum in the growth medium (Fig. 1 A) . The addition of up to 250 #g/ml ironsaturated holotransferrin, in contrast, did not inhibit Candida growth. Furthermore, inhibition of Candida growth in 5% serum could be completely reversed by the addition of increasing concentrations of ferric nitrate to the growth medium (Fig. 2) , indicating that serum-induced growth inhibition is the result of iron restriction.
To determine if Candida could utilize hemoglobin as an iron source, medium containing 5% serum was supplemented with increasing concentrations of hemoglobin or heme, the iron-containing moiety of hemoglobin (Fig. 2) . Both hemoglobin and heme restored Candida growth in serum. Protoporphyrin IX, the heme precursor that does not contain iron, did not, however, support Candida growth.
Taken together, these results indicate that growth inhibition of C. albicans hyphae in human serum is due to iron restriction, and that C. albicans grown under these conditions is unable to effidently access iron bound by transferrin. Iron from hemoglobin, however, is accessible to Candida and restores hyphal growth in serum.
Complement-Opsonized SRBC Rosette C albicans Hyphae and Restore C albicans Growth in Serum. Since hemoglobin is sequestered in RBC, heme-derived iron is generally inaccessible to pathogenic microorganisms. We hypothesized that C. albicans has a mechanism for obtaining heme-derived iron from RBC, and that this mechanism involves binding of RBC to Candida via CR-like molecules. To test this, C. albicans hyphae were cultured for 18 h in the presence of SRBC opsonized with complement. Hyphae formed rosettes with opsonized SRBC (Fig. 3 A) , but not unopsonized SRBC (Fig.  3 B) , after 1 h in culture. If binding of RBC to complement receptors on Candida enables the organism to obtain RBCderived iron, it would be expected that opsonized, but not unopsonized, SRBC would restore Candida growth in serum.
As shown in Fig. 3 (13, 15, 32) . When C. albicans hyphae were preincubated with two anti-human CR3 mAbs, LPM19c and 14B6E.2, rosetring to iC3b-coated SRBC was inhibited (data not shown), and the capacity of complement-coated SRBC to restore Candida growth in serum was dramatically decreased (Fig. 4) . The two antibodies in combination almost completely reversed the opsonized SRBC-induced growth of Candida in serum. An isotype-matched control mAb, R6.5, which is specific for ICAM-1, had no effect on opsonized SRBC-induced Candida growth. Candida growth in iron-sufficient medium, in the absence of serum and SRBC, was not inhibited by mAbs to the CR3 (Fig. 4, legend) . These results indicate that binding of RBC to Candida hyphae via surface CR-like molecules enhances growth of the organism under conditions of iron limitation.
Uptake of SgFe from Complement-opsonized, Rodiolabded RBC. To demonstrate directly that C. albicans is able to obtain iron from RBC bound to complement receptors, RRBC were radiolabded in vivo with SgFe, and the uptake of radiolabeled iron by iron-deprived Candida was measured. As shown in Fig. 5 , Candida grown in serum acquired significantly more radiolabeled iron from opsonized than from unopsonized RRBC. Moreover, uptake of iron from opsonized RRBC was inhibited by antibodies to the human CK3. We condude, therefore, that C. albicans has a mechanism for obtaining heme-derived iron from RBC and that binding of RBC to CR-like molecules on Candida is a requisite step in this mechanism.
"Bystander' Deposition of C3 Fragments on RBC as a Result of Alternative Pathway Activation by C. albicans. For
Candida to utilize the above mechanism for iron acquisition in the human host, the C3-derived ligands for Candida CR-like molecules must be present on HRBC. Others have shown that activation of complement can lead to deposition of C3 fragments not only on the surface of the complement activator itself, but also on host tissues in the vicinity of activation (33, 34) . Indeed, complement activation by C. albicans was found to lead to deposition of complement components along the basement membranes in cutaneous lesions of patients with chronic mucocutaneous candidiasis (35) . We hypothesized that in the presence of fresh human serum, complement would become deposited on autologous RBC by a "bystander" mechanism after activation of the alternative complement pathway (36) by C. albicans. To test this hypothesis, we cultured Candida hyphae with H R B C in the presence of fresh autologous serum or serum treated to inactivate complement. After 1 h at 37~ the cultures were examined for Candida-RBC rosettes. In addition, rosetting was measured spectrophotometricaUy by the amount of hemoglobin released after water lysis of bound HRBC. Rosetting occurred in all wells in which the alternative complement pathway was intact, including wells that received fresh, autologous serum and serum treated with EGTA/Mg a+ (Table 1) . Rosetting did not occur under conditions in which the alternative pathway was rendered nonfunctional, including serum that was exposed to heat (56~ 45 rain), treated with EDTA, or immunologically depleted of C3 (Table 1) . Photomicrographs of C. albicans cultured with H R B C and fresh or heat-inactivated serum are shown in Fig. 6 . These results indicate that in an autologous human system, activation of the alternative pathway of complement by C. albicans can lead to complement deposition on "bystander" tLBC, and consequently to Candida-RBC rosetting.
To show directly that C3 degradation fragments may become deposited on H R B C as a result of alternative pathway activation by Candida, H R B C that were washed from rosetted and nonrosetted wells were analyzed by flow cytometry for the presence of surface C3 fragments using a mAb specific for human iC3b. A significant percentage of H R B C washed from rosetted wells (those that received fresh serum), but not nourosetted wells (those that received heat-inactivated 1647 Moors et al. Figure 5 . C albicans hyphae take up radiohbeled iron from complementcoated PdLBC. C. albicans were cultured with opsonized or unopsonized 59Fe-labeled RRBC as described in Materials and Methods. In one sample, hyphae were preineubated for 30 min at 37~ with 4/xg/well anti-human CR3 mAb LPM19c before addition of opsonized RRBC. Results are expressed as cpm of S9Fe taken up by C. albicans. Results shown are from one of three experiments. In three independent experiments, the ratio of cpm taken up by C. albicans from opsonized KRBC compared with unopsonized RRBC ranged from 3 to 10. serum), were positive for bound human iC3b (Fig. 7) . These results indicate that activation of the human alternative pathway by Candida in the presence of HRBC leads to deposition of the ligands for Candida CR-like molecules on the surface of host ILBC by a "bystander" mechanism, resulting in Candicla-RBC rosetting.
Discussion
Molecules that mimic mammalian complement-binding proteins are expressed by various pathogenic microorganisms. Expression of CR-l-like molecules by HSV (37, 38) and EBV (39) , and of a decay-accelerating factor-like protein by Trypanosoma cruzi (40) , have been previously reported. In each case it has been speculated that these molecules facilitate survival in the host, possibly by interfering with host complement-mediated lysis (38) (39) (40) (41) . Expression of complementbinding molecules on C. albicans has also been demonstrated (12, 13) . Since these proteins represent potential virulence factors of the organism (12, 13, 16) , it is of interest to determine their function(s).
The human host presents potential pathogens with a highly iron-restricted environment. As a result of their need for iron, pathogenic microorganisms have adapted a variety of mechanisms for obtaining host-derived iron (25, (42) (43) (44) . In fact, the possession of an efficient mechanism for obtaining hostderived iron is a factor that has been shown in some systems to distinguish virulent from avirulent bacterial strains (25) . To access iron from the host, many bacteria and fungi produce siderophores, low molecular weight molecules with high c. albicans hyphae were cultured with HRBC and 10% fresh autologous serum, heat-inactivated (56~ 45 min) serum, serum depleted immunologically of C3, or serum chelated with EDTA, or EGTA/Mg 2+ . After 1 h at 37~ cultures were scored blindly for Candida-HRBC rosettes ( + / -). In addition, rosetting is expressed as the amount of hemoglobin associated with HRBC bound to Candida, and was determined by measuring the absorbance of hemoglobin at 420 nm as described in Materials and Methods. Results are representative of three experiments.
iron-binding affinities. These molecules are able to compete successfuUy with host iron-binding proteins for elemental iron (25) . In addition, some bacteria obtain iron from transferrin by directly binding transferrin-iron complexes (43) , while others have the ability to utilize heine-containing compounds (44) (45) (46) .
Numerous studies have demonstrated serum-induced growth inhibition of C. albicans (17) (18) (19) (20) (21) (22) . In these studies, inhibition was attributed to a variety of factors (20) (21) (22) , however, a number of reports have related serum-induced growth inhibition to the presence of transferrin (18, 23, 24) . In the latter studies it was demonstrated that growth inhibition could be reversed by the addition of exogenous iron. These studies indicated that iron is necessary for the growth of C. albicans. The mechanism(s) by which C. albicans acquires iron for survival in the iron-limiting environment of the human host are largely unknown.
In the present report we propose a novel mechanism by which C. albicans may obtain iron for growth in the human host, which involves the use of CR-like molecules. Specifically, we have shown that expression by C. albicans of a molecule with iC3b-binding activity enables the organism to bind host RBC and obtain heme-derived iron for growth. Evidence to support this model is as follows: (a) C. albicans hyphae rosette complement-opsonized, but not unopsonized RBC; (b) in the presence of inhibitory concentrations of serum, growth of C. albicans is increased up to 50-fold as a result of Candida-RBC rosetting. Unopsonized, non-rosetted RBC have little effect on Candida growth in serum; (c) rosetting of Candicla to complement-opsonized RBC is inhibited by monoclonal antibodies to the human CR3. Inhibition of rosetting correlates with inhibition of opsonized SRBC-induced Candida growth; (e) rosetting of hyphae to opsonized, radiolabeled RBC results in the uptake of radiolabeled iron by Can- Figure 6 . Activation of the alternative pathway of complement by (3. albicans results in "bystander" deposition of complement on autologous RBC. Photomicrographs of Candida hyphal colonies that were cultured for 1 h as described in Materials and Methods with HRBC + 10% fresh autologous serum (.4) or heat-inactivated autologous serum (B).
dida. Radiolabeled iron uptake is inhibited by antibodies to the human CR3.
That unopsonized RBC do not restore Candida growth in the manner observed with opsonized RBC indicates that dose contact between C.and/ah and RBC, mediated by a specific receptor-ligand interaction, is a necessary prerequisite for uptake of RBC-derived iron by Candida. The importance of this interaction for uptake of RBC-derived iron is further The production of siderophores by C. albicans has been reported (42, 47) , but the conditions under which Candida utilizes these molecules have not been described in detail. It is clear that in our system, however, Candida-derived siderophores do not function e~ciently (Fig. 1) . C. albicans, in addition to being a potential pathogen, is a commensal organism in the human gut, where an abundance of nutrients, including elemental iron, are available as a result of digestive. processes. It is possible that under circumstances such as these, in which iron is not bound by transferrin, that Candida-derived siderophores operate to scavenge iron. Acquisition of iron from RBC by the mechanism that we describe may be important in disseminated candidiasis, at sites of invasive infection such as kidney and liver, where elemental iron is not readily available and where there is an abundance of RBC. In addition, C. albicans may utilize this mechanism in mucocutaneous lesions in which the organism has penetrated the superficial layers of the skin resulting in an inflammatory response (35, 48) . It is likely that the ability to utilize more than one mechanism for iron acquisition, depending upon the local environment, would contribute to the pathogenic versatility of the organism.
The method of iron acquisition that we propose would be dependent upon the presence of the CR3 ligand, iC3b, on the surface of host RBC. It is a well described phenomenon that complement activation can lead not only to deposition of complement component C3b on the surface of the complement activator, but also in the fluid phase (49) and on the surface of surrounding host tissues (33, 34) . In lesions of patients with chronic mucocutaneous candidiasis (35) , as well as in an experimental animal model (48) , C3 fragments were detected on the surface of host tissues as well as on the surface of C, albicans as a result of complement activation. Similarly, we have shown that activation of the alternative complement pathway by C. albicans can result in deposition of C3 fragments on the surface of surrounding autologous RBC (Figs. 6 and 7) . Once deposited by this "bystander" effect, C3b would become degraded by serum factors H and I to its inactive form, iC3b, the CR3 ligand. Moreover, this process would be facilitated by the presence of CR1 on HRBC (50) . CR1 has factor I cofactor activity for the conversion of C3b to iC3b, and further to C3dg (50), a fragment that has also been shown to bind Candida CR-like molecules (12-14).
Others have proposed that the Candida CR3, like the mammalian CR3, which is a member of the integrin family of proteins (51) , functions as an adhesion molecule, promoting the adherence of Candida to host tissues (16, 52) . The host tissue ligand for this interaction, however, has not been determined. In light of the data presented here, the possibility that C3 degradation fragments may also serve as adherence ligands for Candida CR-like molecules deserves consideration.
In summary, we propose a novel mechanism of iron acquisition by C. albicans, which involves the use of molecules that mimic host complement receptors. In addition, we show that C. albicans can utilize hemoglobin horn RBC as an iron source. To our knowledge, this is the first report of the utilization of a heine-containing compound as an iron source by a pathogenic fungus. We are currently investigating whether C. albicans acquires RBC-derived iron by a hemoglobin receptor, similar to certain bacteria (T. L. Stull, unpublished results).
The predisposition of certain immunocompromised patients to infection with C. albicans is clearly a result of host factors such as leukocyte defidendes and prolonged exposure to chemotherapeutic agents (4) . However, the ability of C. albicans to persist in mucocutaneous and disseminated lesions may be facilitated by the ability of the organism to exploit the host complement system to acquire and utilize host RBC-derived iron. The use of CR-like molecules for iron acquisition by C. albicans may therefore be an important virulence factor of the organism.
